USA - FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabete (Catapult's regulatory round-up - June)
Fiche du document
21 février 2024
- doi: 10.58079/vvnb
info:eu-repo/semantics/openAccess
Sujets proches
Type 1 diabetes Brittle diabetes IDDM (Disease) Ketosis prone diabetes Diabetes mellitus Insulin-dependent diabetes Therapy, Cellular Cells--Therapeutic use Cell therapyCiter ce document
adelage, « USA - FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabete (Catapult's regulatory round-up - June) », ELSIBI, ID : 10.58079/vvnb
Métriques
Partage / Export
Résumé
FDA has approved the first allogeneic pancreatic islet cellular therapy for the treatment of adults with Type 1 diabetes who are unable to approach target HbA1c because of current repeated episodes of severe hypoglycemia despite intensive diabetes management and education. Published on the 3rd of July 2023. Read the Regulatory Round-up – June 2023 (catapult.org.uk) following this link.